Structure Therapeutics Inc. (NASDAQ:GPCR) is one of the best small cap stocks with biggest upside potential. On August 7, Guggenheim lowered the firm’s price target on Structure Therapeutics to $90 ...
Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results